Canada Pension Plan Investment Board’s Catalyst Pharmaceutical CPRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$354K	Hold	14,300	–	–	﹤0.01%	1356
2025 Q4	$334K	Buy	+14,300	New	+$319K	﹤0.01%	1474
2025 Q1	–	Sell	-59,600	Closed	-$1.24M	–	1343
2024 Q4	$1.24M	Buy	+59,600	New	+$1.28M	﹤0.01%	970
2023 Q1	–	Sell	-53,800	Closed	-$1M	–	1090
2022 Q4	$1M	Buy	+53,800	New	+$828K	﹤0.01%	858

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Canada Pension Plan Investment Board's CPRX Position: Q1 2026 in Review

Canada Pension Plan Investment Board held its Catalyst Pharmaceutical (CPRX) position steady in Q1 2026 at 14,300 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

Canada Pension Plan Investment Board first reported a position in CPRX in Q4 2022 and has held it in 4 quarters since. The position peaked at $1.24M in Q4 2024. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

Canada Pension Plan Investment Board held 14,300 shares of Catalyst Pharmaceutical worth $354K as of Q1 2026.
Canada Pension Plan Investment Board left its Catalyst Pharmaceutical share count unchanged in Q1 2026.
Catalyst Pharmaceutical made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1356 holding.
Canada Pension Plan Investment Board first reported a position in Catalyst Pharmaceutical in Q4 2022 and has held it in 4 quarters since.
Canada Pension Plan Investment Board's Catalyst Pharmaceutical position peaked at $1.24M in Q4 2024.
380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.